Live tape
Top 8, mentions 7d14,334NVDA4,850 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,736 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,106 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK861 mentions▲ +0.05

Equity · Healthcare

SLDB

NASDAQ

Solid Biosciences (SLDB)

8.71 USD −3.60% vs prior close
Solid Biosciences Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
972.1M USD
EPS, diluted, year to Dec 2025
−1.99 USD
52-week range
4 USD – 11.15 USD
Avg volume
453.0K

as of Jul 17, 2026

Have Solid Biosciences (SLDB) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Solid Biosciences insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 6 Oct 2025, show no open-market purchase.

Form 4, 90 days to 10 Nov 2026, newest reported trade 19 Oct 2026

0buys
1sells
$25Knet sold
2other filings
Have Solid Biosciences (SLDB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
19 Oct 2026Brooks GabrielChief Medical OfficerSell4,37425K USD
2 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Solid Biosciences (SLDB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
18 Oct 2026Brooks GabrielChief Medical OfficerOption exercise9,750
02 Oct 2026SMITH IAN FDirectorOption exercise3,440

Which funds hold Solid Biosciences (SLDB)?

1 of the 45 institutional funds we track reported a Solid Biosciences position for the quarter ended 30 Sep 2026 — a combined 754K USD; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold Solid Biosciences (SLDB)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementHeld (±25%)104,314754K USD+0.8%

What has been filed or recorded for Solid Biosciences (SLDB)?

The filings we hold for Solid Biosciences, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Solid Biosciences (SLDB)?
And
13 Oct 2026Fails to deliverShares failed to deliver40 shares268 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.36 USD
30 Sep 2026FinancialsTotal assets389.9M USDat period end
30 Sep 2026FinancialsTotal equity342.1M USDat period end
29 Sep 2026Fails to deliverShares failed to deliver16 shares116 USD notional · <0.001% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.38 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.52 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −1.99 USD
31 Dec 2025FinancialsNet income−174.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.99 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.48 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.42 USD
31 Mar 2025Quarterly earningsQ2 2025 reportedEPS −0.42 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −3.06 USD

What do people ask about Solid Biosciences (SLDB)?

From live data
What is Solid Biosciences’ market cap?972.1M

Solid Biosciences is worth 972.1M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

Have Solid Biosciences insiders bought or sold shares recently?1 sale

In the 90 days to 10 Nov 2026, Solid Biosciences insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 6 Oct 2025, show no open-market purchase. A further 2 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Solid Biosciences?1 of 45

1 of the 45 funds we track reported a Solid Biosciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

When did Solid Biosciences last report earnings?−0.36

Solid Biosciences last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.36 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings